Michelle L. Swearingen

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial

Sally Arai, Richard Meagher, Michelle L. Swearingen et al. · Cytotherapy · 2008 · 429 citations

Medicine, Immunology, Oncology +10

VCC-1, a novel chemokine, promotes tumor growth

Edward J. Weinstein, Richard Head, David W. Griggs et al. · Biochemical and Biophysical Research Communications · 2006 · 88 citations

Medicine, Cancer Biology, Oncology +14

Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody

Jeffrey S. Boyles, Catherine B. Beidler, Beth A. Strifler et al. · mAbs · 2020 · 24 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Somatic Mutations in CCK2R Alter Receptor Activity that Promote Oncogenic Phenotypes

Melinda D. Willard, Mary E. Lajiness, Isabella H. Wulur et al. · Molecular Cancer Research · 2012 · 21 citations · Full text

Medicine, Genetics, Oncology +15

Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array

Michelle L. Swearingen, Duo Sun, Maureen Bourner et al. · Cancer Letters · 2003 · 20 citations

Life Sciences, Genetics, Molecular Biology +13